MB-6(MUSTBIO)

N/A

Report date: 2024/06/20 14:17:02

Base Information

Drug NameMB-6(MUSTBIO)
Drug Alias NameMB-6(MUSTBIO)MB6(MUSTBIO)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionTumor-associated antigen modulatorsT cell surface glycoprotein CD3 modulators
TargetsTumor-associated antigenT cell surface glycoprotein CD3
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMUSTBIO Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMUSTBIO Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A